Merz Pharmaceuticals, LLC's Belotero(R) Balance PMA Filing Formally Accepted for Review by the FDA
GREENSBORO, N.C., Sept. 11 /PRNewswire/ -- Merz Pharmaceuticals, LLC, a
leading specialty pharmaceutical company, today announced that the U.S. Food
and Drug Administration (FDA) has accepted for review Merz's premarket
approval (PMA) application for Belotero(R) Balance.